Search & Analyze

Wockhardt Ltd.

HealthcarePharmaceuticals & Drugs

www.wockhardt.com BSE: 532300NSE: WOCKPHARMA

₹2,207.35BSE4.01%

07 Sep, 4:01 PM

₹2,207.35

₹35.87K Cr

87.70

7.12

4.29%

₹2,235.50

₹2,079.00

₹2,420.00

₹1,086.80

Customise metrics bar

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,899.80	37.69	4,55,825.66	0.84	2,901.23	26.53%	15,299.88	10.46%	19.11
DIVI'S LAB. DIVISLAB	9,305.00	84.45	2,47,018.51	0.32	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,913.00	85.68	1,86,874.73	0.77	566.00	3.28%	4,921.00	54.85%	19.27
ZYDUSLIFE ZYDUSLIFE	1,155.00	25.53	1,15,211.69	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,395.95	33.46	1,12,773.00	0.93	785.55	-39.18%	7,119.28	2.33%	16.00
LAURUSLABS LAURUSLABS	1,868.25	92.32	1,00,943.83	0.11	362.07	123.94%	2,026.31	29.10%	18.20
LUPIN LTD. LUPIN	2,105.00	17.41	96,254.46	0.86	1,416.98	16.01%	8,276.89	32.04%	28.86
Wockhardt Ltd. WOCKPHARMA	2,207.35	87.70	35,867.71	0.00	107.00	199.07%	929.00	25.88%	6.79

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	739.00	809.00	721.00	743.00	738.00	782.00	888.00	965.00	929.00
Expenses	648.00	699.00	593.00	679.00	666.00	604.00	711.00	740.00	737.00
	91.00	110.00	128.00	64.00	72.00	178.00	177.00	225.00	192.00
	12.31%	13.60%	17.75%	8.61%	9.76%	22.76%	19.93%	23.32%	20.67%
	30.00	9.00	8.00	15.00	-77.00	21.00	15.00	67.00	31.00
Interest	73.00	73.00	60.00	48.00	48.00	55.00	60.00	50.00	52.00
	54.00	55.00	55.00	53.00	56.00	53.00	65.00	53.00	55.00
	-6.00	-9.00	21.00	-22.00	-109.00	91.00	67.00	189.00	116.00
	-166.67%	-77.78%	4.76%	-104.55%	0.92%	9.89%	8.96%	13.23%	7.76%
	-14.00	-22.00	14.00	-25.00	-90.00	78.00	59.00	166.00	106.00
	-0.91	-1.43	0.86	-1.54	-5.56	4.81	3.64	10.25	6.54

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	5,132.00	4,273.00	3,605.00	3,867.00	3,880.00
	3,230.00	2,651.00	2,798.00	3,012.00	3,373.00
EXPENDITURE :
Increase/Decrease in Stock	87.00	84.00	-14.00	-53.00	-128.00
Raw Material Consumed	1,180.00	1,027.00	1,179.00	1,185.00	1,260.00
Power & Fuel Cost	98.00	103.00	107.00	113.00	120.00
Employee Cost	749.00	637.00	629.00	651.00	725.00
Other Manufacturing Expenses	169.00	126.00	142.00	171.00	204.00
General and Administration Expenses	224.00	192.00	190.00	196.00	218.00
Selling and Distribution Expenses	180.00	134.00	125.00	137.00	154.00
Miscellaneous Expenses	245.00	247.00	401.00	219.00	194.00
	2,932.00	2,550.00	2,759.00	2,619.00	2,747.00
Operating Profit (Excl OI)	298.00	101.00	39.00	393.00	626.00
	20.00	122.00	83.00	62.00	137.00
	318.00	223.00	122.00	455.00	763.00
Interest	299.00	302.00	305.00	254.00	213.00
PBDT	19.00	-79.00	-183.00	201.00	550.00
	247.00	251.00	223.00	217.00	227.00
Profit Before Taxation & Exceptional Items	-228.00	-330.00	-406.00	-16.00	323.00
Exceptional Income / Expenses	-183.00	-294.00	-14.00		-85.00
	-411.00	-624.00	-420.00	-16.00	238.00
Provision for Tax	-132.00	-3.00	52.00	41.00	39.00
	-279.00	-621.00	-472.00	-57.00	199.00
Extra items				0.00	0.00
Minority Interest	35.00	62.00	9.00	10.00	14.00
Consolidated Net Profit	-244.00	-559.00	-463.00	-47.00	213.00
Profit Balance B/F	1,529.00	1,276.00	710.00	240.00	189.00
Appropriations	1,285.00	717.00	247.00	193.00	402.00
	-16.94	-38.82	-30.06	-2.90	13.15
Adjusted EPS	-16.94	-38.82	-30.06	-2.90	13.15

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	72.00	72.00	77.00	81.00	81.00
Share Warrants & Outstandings	18.00	16.00	13.00	11.00	13.00
Total Reserves	3,759.00	3,266.00	3,269.00	4,261.00	4,846.00
Reserve excluding Revaluation Reserve	3,759.00	3,266.00	3,269.00	4,261.00	4,846.00
	3,849.00	3,354.00	3,359.00	4,353.00	4,940.00
Minority Interest	353.00	308.00	303.00	304.00	341.00
Secured Loans	260.00	222.00		274.00	769.00
Unsecured Loans	95.00	2.00	891.00	937.00	749.00
Deferred Tax Assets / Liabilities	-545.00	-576.00	-544.00	-514.00	-440.00
Other Long Term Liabilities	419.00	304.00	242.00	161.00	117.00
Long Term Provisions	32.00	26.00	28.00	29.00	40.00
Total Non-Current Liabilities	261.00	-22.00	617.00	887.00	1,235.00
Trade Payables	921.00	867.00	766.00	592.00	563.00
Other Current Liabilities	1,197.00	1,172.00	1,144.00	886.00	581.00
Short Term Borrowings	1,034.00	1,330.00	832.00	496.00	438.00
Short Term Provisions	55.00	66.00	49.00	68.00	40.00
Total Current Liabilities	3,207.00	3,435.00	2,791.00	2,042.00	1,622.00
Total Liabilities	7,670.00	7,075.00	7,070.00	7,586.00	8,138.00
Gross Block	6,019.00	5,696.00	5,721.00	5,814.00	6,164.00
Less: Accumulated Depreciation	2,557.00	2,654.00	2,840.00	3,078.00	3,373.00
Net Block	3,462.00	3,042.00	2,881.00	2,736.00	2,791.00
Capital Work in Progress	389.00	414.00	434.00	513.00	671.00
Long Term Loans & Advances	259.00	269.00	266.00	246.00	251.00
Other Non Current Assets	18.00	17.00	17.00	2.00	20.00
Total Non-Current Assets	5,081.00	4,867.00	4,886.00	5,017.00	5,441.00
Currents Investments				422.00	412.00
Inventories	769.00	658.00	640.00	725.00	887.00
Sundry Debtors	918.00	797.00	618.00	661.00	588.00
Cash and Bank	406.00	124.00	529.00	191.00	250.00
Other Current Assets				4.00	73.00
Short Term Loans and Advances	352.00	335.00	286.00	462.00	396.00
Total Current Assets	2,445.00	1,914.00	2,073.00	2,465.00	2,606.00
Net Current Assets (Including Current Investments)	-762.00	-1,521.00	-718.00	423.00	984.00
Total Assets	7,670.00	7,075.00	7,070.00	7,586.00	8,138.00
Contingent Liabilities	840.00	866.26	882.46	770.26	768.26
Total Debt	1,862.00	1,887.00	2,112.00	1,859.00	2,125.00
	266.04	231.81	217.27	268.02	304.14
Adjusted Book Value	266.04	231.81	217.27	268.02	304.14

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	-411.00	-624.00	-420.00	-16.00	238.00
Adjustment	554.00	635.00	677.00	455.00	455.00
Changes In working Capital	367.00	153.00	-8.00	-492.00	-282.00
Cash Flow after changes in Working Capital	510.00	164.00	249.00	-53.00	411.00
Cash Flow from Operating Activities	413.00	153.00	219.00	-22.00	390.00
Cash Flow from Investing Activities	-201.00	-125.00	-137.00	-783.00	-241.00
Cash Flow from Financing Activitie	-71.00	-315.00	334.00	409.00	-54.00
Net Cash Inflow / Outflow	141.00	-287.00	416.00	-396.00	95.00
Opening Cash & Cash Equivalents	232.00	370.00	90.00	505.00	112.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger					-4.00
Effect of Foreign Exchange Fluctuations	-3.00	7.00	-1.00	3.00	14.00
Closing Cash & Cash Equivalent	370.00	90.00	505.00	112.00	217.00

Ratios

Valuation

87.70

7.12

42.22

10.06

25.17

309.81

Profitability

4.29

6.79

2.53

16.13

5.13

Leverage & Liquidity

0.43

1.61

2.12

Returns

0.00

0.49

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	51.99	51.99	49.09	49.09	49.09	49.08	49.08	49.08	49.08
	10.39	11.81	16.38	17.42	18.31	18.12	17.55	18.08	16.47
	37.61	36.21	34.53	33.49	32.60	32.80	33.36	32.84	34.45
	48.01	48.01	50.91	50.91	50.91	50.92	50.92	50.92	50.92
No. of Shareholders	1,40,391	1,38,142	1,42,710	1,41,799	1,46,918	1,37,946	1,42,274	1,39,016	1,66,518

Corporate Actions

Showing: All

Date	Type	Details
2026-08-04	Board Meeting	Quarterly Results
2026-07-20	AGM
2026-04-28	Board Meeting	Audited Results Inter alia, to consider and approve:- (i) raising of funds by issue of Equity Shares, Equity Shares through depository receipt including Global Depository Receipts , American Depository Receipts , Foreign Currency Convertible Bonds , Fully Convertible Debentures , Partly Convertible Debentures OCD, and /or NCD and/ or other securities convertible into Equity Shares with or without warrants and/ or convertible preference shares or any security convertible into Equity Shares, or any combination of such securities in one or more tranches by way of one or more public and/ or private offerings including QIP and/or on preferential allotment basis or any combination thereof or any other method as may be permitted.

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Wockhardt Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

10 members across the board and senior leadership

Rashmi Mamtura

Company Secretary & Compliance Officer

—

Habil Khorakiwala

Chairman

₹5.00 Cr

Mar '26

Vinesh Kumar Jairath